• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 837-844.DOI: 10.3969/j.issn.1671-2587.2026.05.023

• 综述 • 上一篇    下一篇

母乳同种抗体介导的胎儿及新生儿溶血病研究现状*

米叶沙尔·安尼娃尔1, 邱进2, 李菲2, 陈伟2   

  1. 1新疆维吾尔自治区人民医院白鸟湖医院(西安交通大学第二附属医院新疆医院)输血科,新疆乌鲁木齐 830022;
    2新疆维吾尔自治区人民医院输血科,新疆乌鲁木齐 830001
  • 收稿日期:2026-09-02 修回日期:2026-09-18 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 陈伟,主要从事临床输血治疗与血型免疫血清学研究,(E-mail)29286889@qq.com。
  • 作者简介:米叶沙尔·安尼娃尔,主要从事输血免疫相关研究,(E-mail)524496683@qq.com。
  • 基金资助:
    *本课题受新疆维吾尔自治区人民医院白鸟湖医院(西安交通大学第二附属医院新疆医院)院内项目(No.BNH-Y202601),新疆维吾尔自治区“天山英才”医药卫生高层次人才项目(No.TSYC202401B157),新疆第二医学院科研项目(No.ZR202624)资助

Research Status of Breast Milk-Derived Alloantibody-Mediated Hemolytic Disease of the Fetus and Newborn

MIYESSAR Anwar1, QIU Jin2, LI Fei2, CHEN Wei2   

  1. 1Department of Blood Transfusion, People's Hospital of Xinjiang Uygur Autonomous Region Bainiaohu Hospital (The Second Affiliated Hospital of Xi'an Jiaotong University Xinjiang Hospital), Urumqi 830022;
    2Department of Blood Transfusion, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001
  • Received:2026-09-02 Revised:2026-09-18 Online:2026-10-20 Published:2026-11-11

摘要: 胎儿及新生儿溶血病(hemolytic disease of the fetus and newborn, HDFN)的经典发病机制是母体IgG同种抗体经胎盘FcRn转运进入胎儿循环,引起胎儿红细胞免疫性破坏。该机制可解释多数患儿的宫内及出生后早期表现,但对部分患儿出生后数周仍存在持续性或迟发性溶血的解释上存在局限性。近年来的病例报告提示,母乳中的红细胞同种抗体可能经新生儿肠道吸收进入循环,参与产后溶血的维持。本文在现有病例汇总的基础上,对母乳抗体的来源、新生儿肠道吸收的生理学依据、相关病例的临床特征、检测方法及因果判断进行综述。母乳同种抗体的检测目前沿用血清学方法,标本处理和效价报告及致病阈值均缺乏标准化。从机制上看,母乳抗体更可能发挥“维持打击”作用,在胎盘来源抗体尚未清除的窗口期内延长溶血病程,而非独立启动HDFN。现有证据尚不足以支持将母乳抗体介导的溶血列为独立的第五种致病机制。未来需要前瞻性队列研究明确其临床发生率,并建立标准化的检测与干预策略。

关键词: 胎儿及新生儿溶血病, 母乳, 同种抗体, Fc受体

Abstract: The classic pathogenesis of hemolytic disease of the fetus and newborn (HDFN) is that maternal IgG isoantibody is transported into fetal circulation through placental FcRn, which causes immune damage of fetal red blood cells. This mechanism can explain the intrauterine and early postnatal manifestations of most children, but there are limitations in explaining that some children still have persistent or delayed hemolysis several weeks after birth. Case reports in recent years suggest that red blood cell alloantibodies in breast milk may be absorbed into the circulation through the neonatal intestine and participate in the maintenance of postpartum hemolysis. Based on the summary of existing cases, this paper reviews the source of breast milk antibody, the physiological basis of neonatal intestinal absorption, the clinical characteristics, detection methods and causal judgment of related cases. Detection of breast milk alloantibodies currently relies on serological methods, and sample processing, titer reporting, and pathogenic thresholds all lack standardization. From the mechanism point of view, breast milk antibody is more likely to play the role of "maintaining attack" and prolong the course of hemolysis during the window period when placental antibody has not been cleared, rather than starting HDFN independently. The existing evidence is not enough to support the classification of antibody-mediated hemolysis in breast milk as an independent fifth pathogenic mechanism. Prospective cohort study is necessary in the future to clarify its clinical incidence and establish standardized detection and intervention strategies.

Key words: Hemolytic disease of the fetus and newborn, Breast milk, Alloantibody, FcRn

中图分类号: